Catalyst Wire Dossier Catalyst Wire Dossier

Levomilnacipran ER

levomilnacipran hydrochloride · Zhejiang Huahai Pharmaceutical Co., Ltd.
Drug timelines are a Plus or Pro feature.

8 regulatory and trial events tracked for Levomilnacipran ER, covering 2013-10-25 to 2025-11-28. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety Study of Levomilnacipran Hydrochloride Extended-Release Capsules in Major Depressive Disorder [Phase 3]

See pricing